81
views
0
recommends
+1 Recommend
0 collections
    1
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Infliximab for induction and maintenance therapy for ulcerative colitis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor alpha, is an established treatment for Crohn's disease but not ulcerative colitis.

          Related collections

          Author and article information

          Journal
          N Engl J Med
          The New England journal of medicine
          Massachusetts Medical Society
          1533-4406
          0028-4793
          Dec 08 2005
          : 353
          : 23
          Affiliations
          [1 ] University Hospital Gasthuisberg, Leuven, Belgium. paul.rutgeerts@uz.kuleuven.ac.be
          Article
          353/23/2462
          10.1056/NEJMoa050516
          16339095
          edfb83a4-25c0-46e5-950e-d901b9f79951
          Copyright 2005 Massachusetts Medical Society.
          History

          Comments

          Comment on this article